Another 20 volunteers received the Russian vaccine for the prevention of coronavirus, the test the Russian defense Ministry and scientists from the center for epidemiology and Microbiology them. N. F. Gamalei. The results of the first tests allowed to continue the clinical trials, have informed RBC in the Ministry of defence.
The second group of volunteers first introduced the one component of domestic combined vector vaccines, and three weeks later the second. After drug administration the condition of the volunteers appreciated the doctors, serious adverse reactions have been identified, according to the Agency.
Clinical trials of a vaccine against COVID-19 began on 18 June, vaccinable 18 volunteers. Had been organized tests of the vaccine on large and small animals, the permission to conduct clinical trials on humans have given the Ministry of health.
Half the study participants entered a single component vaccine, the rest second. The vaccine was tested in the hospital. academician N. N. Burdenko.
Trial participants are isolated in a hospital and are under the supervision of physicians. The study will be completed by the end of July.
22 June, the Director of the National research centre of epidemiology and Microbiology them. N. F. Gamalei Alexander Ginzburg said that it can take up to 70 million doses of the drug to begin mass vaccination of people from COVID-19.
More Stories
Color wheel online
The Ministry of health has promised to disclose information about the vaccine trials from COVID-19
Called “atypical” symptoms of coronavirus